Enlivex Therapeutics Ltd. has announced the appointment of Dr. Oren Hershkovitz as Chief Executive Officer, effective November 16, 2019. Dr. Hershkovitz served for nearly a decade in managerial and executive roles at PROLOR Biotech Inc. and OPKO Biologics Ltd., the biotech subsidiary of OPKO Health Inc. acting as General Manager of OPKO Biologics for the past four years. Dr. Hershkovitz successfully managed more than 70 employees and led manufacturing, non-clinical and clinical development for various Phase I, II and III programs, including for obesity, hemophilia and growth hormone deficiency.